China to test its Ebola vaccine on humans

Image
Press Trust of India Beijing
Last Updated : Dec 25 2014 | 6:41 PM IST
China today said it has developed a vaccine to combat the spread of deadly Ebola virus that has killed more than 7,000 people in three West African countries, and the test of the drug on humans would begin this month.
Defence Ministry spokesman Yang Yujun told reporters that the vaccine has been developed by a research team at the Academy of Military Medical Sciences, one of the top research units of China's People's Liberation Army.
"The vaccine has recently passed appraisal by state and military authorities and will begin clinical tests in December," said Yang.
He said the China-developed Ebola vaccine was the third in the world to have been put into clinical tests in the world. It is also the world's first 2014-genetic mutation Ebola vaccine.
Yang said that since September, the Chinese military has sent some 300 medical personnel and specialists to Sierra Leone and Liberia in eastern Africa to help control the epidemic.
Scientists around the world are racing to develop Ebola vaccines after the world's worst outbreak of the virus, which has killed more than 7,000 people in the worst-hit countries of Sierra Leone, Liberia and Guinea in West Africa.
Yang said the Chinese medical teams have worked closely with the World Health Organisation, Doctors Without Borders, local governments and the UN peacekeeping mission in Liberia to jointly combat the spread of the deadly disease.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 25 2014 | 6:41 PM IST

Next Story